(a) Specifications. Each milliliter of solution contains prochlorperazine edisylate equivalent to 4 milligrams (mg) prochlorperazine and isopropamide iodide equivalent to 0.28 mg of isopropamide.
(b) Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.
(c) Conditions of use--(1) Amount. (i) Dosage is administered by subcutaneous injection twice daily as follows: ------------------------------------------------------------------------
Dosage in
Weight of animal in pounds milliliters------------------------------------------------------------------------Up to 4................................................. 0.255 to 14................................................. 0.5-115 to 30................................................ 2-330 to 45................................................ 3-445 to 60................................................ 4-5Over 60................................................. 6------------------------------------------------------------------------
(ii) Following the last injection, administer prochlorperazine and isopropamide sustained release capsules as indicated.
(2) Indications for use. For use in dogs and cats in which gastrointestinal disturbances are associated with emotional stress.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [79 FR 16194, Mar. 25, 2014]